Literature DB >> 11182563

Similarities and differences between free 211At and 125I- transport in porcine thyroid epithelial cells cultured in bicameral chambers.

U Lindencrona1, M Nilsson, E Forssell-Aronsson.   

Abstract

The transport and accumulation of free 211At and 125I- were investigated in thyrocytes cultured as monolayers in bicameral chambers under the influence of thyroid-stimulating hormone, stable iodide, ouabain and perchlorate. The results indicate that there are similarities and differences in the transport mechanisms of free 211At and 125I-. These results will be valuable in the development of radiation protection when handling and using 211At-labeled radiopharmaceuticals, and for the potential use of free 211At in radiation therapy of poorly differentiated thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11182563     DOI: 10.1016/s0969-8051(00)00179-7

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  12 in total

1.  Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.

Authors:  Yun Chen; Brian Kornblit; Donald K Hamlin; George E Sale; Erlinda B Santos; D Scott Wilbur; Barry E Storer; Rainer Storb; Brenda M Sandmaier
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

2.  Astatine Radiopharmaceuticals: Prospects and Problems.

Authors:  Ganesan Vaidyanathan; Michael R Zalutsky
Journal:  Curr Radiopharm       Date:  2008-09-01

3.  The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.

Authors:  Michael J Willhauck; Bibi-Rana Sharif Samani; Ingo Wolf; Reingard Senekowitsch-Schmidtke; Hans-Jürgen Stark; Geerd J Meyer; Wolfram H Knapp; Burkhard Göke; John C Morris; Christine Spitzweg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-11       Impact factor: 9.236

4.  Biodistribution and dosimetry of free 211At, 125I- and 131I- in rats.

Authors:  Johan Spetz; Nils Rudqvist; Eva Forssell-Aronsson
Journal:  Cancer Biother Radiopharm       Date:  2013-06-22       Impact factor: 3.099

5.  Microdosimetric analysis of 211At in thyroid models for man, rat and mouse.

Authors:  Anders Josefsson; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2012-06-09       Impact factor: 3.138

6.  Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back.

Authors:  Byeong-Cheol Ahn
Journal:  Theranostics       Date:  2012-04-11       Impact factor: 11.556

7.  Transcriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles.

Authors:  Nils Rudqvist; Toshima Z Parris; Emil Schüler; Khalil Helou; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2012-06-14       Impact factor: 3.138

8.  Transcriptional response in normal mouse tissues after i.v. (211)At administration - response related to absorbed dose, dose rate, and time.

Authors:  Britta Langen; Nils Rudqvist; Toshima Z Parris; Emil Schüler; Johan Spetz; Khalil Helou; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2015-01-28       Impact factor: 3.138

9.  Transcriptional Response in Mouse Thyroid Tissue after 211At Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after Administration.

Authors:  Nils Rudqvist; Johan Spetz; Emil Schüler; Toshima Z Parris; Britta Langen; Khalil Helou; Eva Forssell-Aronsson
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

10.  Gene expression signature in mouse thyroid tissue after (131)I and (211)At exposure.

Authors:  Nils Rudqvist; Johan Spetz; Emil Schüler; Britta Langen; Toshima Z Parris; Khalil Helou; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2015-10-22       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.